Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 08-Nov-23 4:16 PM View:  | Stankovich Thomas Chief Financial Officer | Reshape Lifesciences Inc. (OBLN) | 25-Oct-23 | Sale | 131 | $0.27 | $35.37 | (< 1%) 23.08K to 22.95K | |
| 08-Nov-23 4:16 PM View: | Stankovich Thomas Chief Financial Officer | Reshape Lifesciences Inc. (OBLN) | 11-Oct-23 | Sale | 39 | $0.93 | $36.27 | (< 1%) 23.12K to 23.08K | |
| 08-Nov-23 4:16 PM View: | Stankovich Thomas Chief Financial Officer | Reshape Lifesciences Inc. (OBLN) | 01-Sep-23 | Sale | 118 | $0.89 | $105.02 | (< 1%) 23.24K to 23.12K | |
| 08-Nov-23 4:16 PM View: | Stankovich Thomas Chief Financial Officer | Reshape Lifesciences Inc. (OBLN) | 24-Aug-23 | Sale | 39 | $1.42 | $55.38 | (< 1%) 23.28K to 23.24K | |
| 08-Nov-23 4:16 PM View: | Stankovich Thomas Chief Financial Officer | Reshape Lifesciences Inc. (OBLN) | 04-Aug-23 | Sale | 108 | $1.43 | $154.44 | (< 1%) 23.38K to 23.28K | |
| 19-Jul-23 4:07 PM View: | Stankovich Thomas Chief Financial Officer | Reshape Lifesciences Inc. (OBLN) | 06-Jul-23 | Sale | 106 | $1.47 | $155.82 | (< 1%) 23.49K to 23.38K | |
| 06-Jul-23 4:16 PM View: | Stankovich Thomas Chief Financial Officer | Reshape Lifesciences Inc. (OBLN) | 30-Jun-23 | Purchase | 17,702 | $1.52 | $26,907.00 | 306% 5.79K to 23.49K | |
| 06-Jul-23 4:16 PM View: | Stankovich Thomas Chief Financial Officer | Reshape Lifesciences Inc. (OBLN) | 31-May-23 | Sale | 98 | $2.41 | $236.18 | (2%) 5.89K to 5.79K | |
| 06-Jul-23 4:16 PM View: | Stankovich Thomas Chief Financial Officer | Reshape Lifesciences Inc. (OBLN) | 30-Apr-23 | Sale | 96 | $2.36 | $226.56 | (2%) 5.98K to 5.89K | |
| 06-Jul-23 4:16 PM View: | Stankovich Thomas Chief Financial Officer | Reshape Lifesciences Inc. (OBLN) | 31-Mar-23 | Sale | 109 | $2.60 | $283.40 | (2%) 6.09K to 5.98K | |
| 07-Mar-23 4:11 PM View: | Stankovich Thomas Chief Financial Officer | Reshape Lifesciences Inc. (OBLN) | 28-Feb-23 | Sale | 103 | $4.25 | $437.75 | (2%) 6.19K to 6.09K | |
| 07-Mar-23 4:11 PM View: | Stankovich Thomas Chief Financial Officer | Reshape Lifesciences Inc. (OBLN) | 02-Feb-23 | Private Sale | 157 | $13.29 | $2,086.53 | (2%) 6.35K to 6.19K | |
| 07-Mar-23 4:11 PM View: | Stankovich Thomas Chief Financial Officer | Reshape Lifesciences Inc. (OBLN) | 24-Jan-23 | Market Sale | 158 | $7.49 | $1,183.49 | (2%) 6.51K to 6.35K | (22%) |
| 20-Dec-22 4:35 PM View: | Stankovich Thomas Chief Financial Officer | Reshape Lifesciences Inc. (OBLN) | 01-Dec-22 | Sale | 7,357 | $0.15 | $1,112.23 | (2%) 332.76K to 325.4K | |
| 20-Dec-22 4:35 PM View: | Stankovich Thomas Chief Financial Officer | Reshape Lifesciences Inc. (OBLN) | 28-Nov-22 | Sale | 364,756 | $0.17 | $61,826.10 | (52%) 697.52K to 332.76K | |
| 20-Dec-22 4:35 PM View: | Stankovich Thomas Chief Financial Officer | Reshape Lifesciences Inc. (OBLN) | 17-Nov-22 | Grant | 364,756 | -- | -- | 110% 332.76K to 697.52K | |
| 10-Nov-22 4:10 PM View: | Stankovich Thomas Chief Financial Officer | Reshape Lifesciences Inc. (OBLN) | 04-Nov-22 | Sale | 8,393 | $0.27 | $2,286.84 | (2%) 341.15K to 332.76K | |
| 06-Oct-22 5:29 PM View: | Stankovich Thomas CFO | Reshape Lifesciences Inc. (OBLN) | 04-Oct-22 | Sale | 8,293 | $0.28 | $2,329.09 | (2%) 346.96K to 338.67K | |
| 12-Sep-22 4:05 PM View: | Stankovich Thomas Chief Financial Officer | Reshape Lifesciences Inc. (OBLN) | 06-Sep-22 | Sale | 4,828 | $0.39 | $1,882.92 | (1%) 351.79K to 346.96K | |
| 11-Aug-22 4:30 PM View: | Stankovich Thomas Chief Financial Officer | Reshape Lifesciences Inc. (OBLN) | 05-Aug-22 | Sale | 4,728 | $0.47 | $2,222.16 | (1%) 356.52K to 351.79K | |
| 11-Aug-22 4:15 PM View: | Bandy Barton P. President and CEO Director | Reshape Lifesciences Inc. (OBLN) | 05-Aug-22 | Sale | 11,674 | $0.47 | $5,486.78 | (1%) 784.77K to 773.1K | |
| 06-Jul-22 4:03 PM View: | Bandy Barton P. President and CEO Director | Reshape Lifesciences Inc. (OBLN) | 01-Jul-22 | Sale | 11,442 | $0.55 | $6,293.10 | (1%) 796.21K to 784.77K | |
| 06-Jul-22 4:08 PM View: | Stankovich Thomas Chief Financial Officer | Reshape Lifesciences Inc. (OBLN) | 01-Jul-22 | Sale | 4,630 | $0.55 | $2,546.50 | (1%) 361.15K to 356.52K | |
| 06-Jun-22 4:49 PM View: | Stankovich Thomas Chief Financial Officer | Reshape Lifesciences Inc. (OBLN) | 01-Jun-22 | Sale | 4,478 | $0.96 | $4,298.88 | (1%) 365.63K to 361.15K | |
| 06-Jun-22 4:58 PM View: | Bandy Barton P. President and CEO Director | Reshape Lifesciences Inc. (OBLN) | 01-Jun-22 | Sale | 11,309 | $0.95 | $10,770.50 | (1%) 807.52K to 796.21K | |
| 01-Jun-22 2:18 PM View: | Stankovich Thomas Chief Financial Officer | Reshape Lifesciences Inc. (OBLN) | 31-May-22 | Private Purchase | 20,000 | $0.92 | $18,422.30 | 6% 345.63K to 365.63K | |
| 12-May-22 4:05 PM View: | Stankovich Thomas Chief Financial Officer | Reshape Lifesciences Inc. (OBLN) | 05-May-22 | Sale | 4,529 | $0.77 | $3,487.33 | (1%) 350.16K to 345.63K | |
| 12-May-22 4:13 PM View: | Bandy Barton P. President and CEO Director | Reshape Lifesciences Inc. (OBLN) | 05-May-22 | Sale | 11,417 | $0.77 | $8,791.09 | (1%) 818.94K to 807.52K | |
| 08-Apr-22 4:12 PM View: | Bandy Barton P. President and CEO Director | Reshape Lifesciences Inc. (OBLN) | 01-Apr-22 | Sale | 11,063 | $1.13 | $12,501.20 | (1%) 830.0K to 818.94K | |
| 08-Apr-22 4:27 PM View: | Stankovich Thomas Chief Financial Officer | Reshape Lifesciences Inc. (OBLN) | 01-Apr-22 | Sale | 5,038 | $1.13 | $5,692.94 | (1%) 355.19K to 350.16K | |
| 02-Mar-22 4:08 PM View: | Bandy Barton P. President and CEO Director | Reshape Lifesciences Inc. (OBLN) | 28-Feb-22 | Sale | 6,538 | $1.06 | $6,930.28 | (< 1%) 836.54K to 830.0K | |
| 02-Mar-22 4:15 PM View: | Stankovich Thomas CFO | Reshape Lifesciences Inc. (OBLN) | 28-Feb-22 | Sale | 3,658 | $1.06 | $3,877.48 | (1%) 358.85K to 355.19K | |
| 02-Feb-22 4:32 PM View: | Bandy Barton P. President and CEO Director | Reshape Lifesciences Inc. (OBLN) | 31-Jan-22 | Sale | 8,324 | $1.22 | $10,155.30 | (< 1%) 844.87K to 836.54K | |
| 02-Feb-22 4:22 PM View: | Stankovich Thomas Chief Financial Officer | Reshape Lifesciences Inc. (OBLN) | 31-Jan-22 | Sale | 3,684 | $1.22 | $4,494.48 | (1%) 362.54K to 358.85K | |
| 28-Jan-22 4:58 PM View: | Bandy Barton P. President and CEO Director | Reshape Lifesciences Inc. (OBLN) | 04-Jan-22 | Sale | 7,150 | $1.79 | $12,798.50 | (< 1%) 852.01K to 844.87K | |
| 28-Jan-22 4:46 PM View: | Stankovich Thomas Chief Financial Officer | Reshape Lifesciences Inc. (OBLN) | 04-Jan-22 | Sale | 3,171 | $1.78 | $5,644.38 | (< 1%) 365.71K to 362.54K | |
| 09-Dec-21 4:22 PM View: | Bandy Barton P. President and CEO Director | Reshape Lifesciences Inc. (OBLN) | 02-Dec-21 | Sale | 13,427 | $1.83 | $24,571.40 | (2%) 865.44K to 852.01K | |
| 09-Dec-21 4:17 PM View: | Stankovich Thomas Chief Financial Officer | Reshape Lifesciences Inc. (OBLN) | 02-Dec-21 | Sale | 4,304 | $1.83 | $7,863.41 | (1%) 370.01K to 365.71K | |
| 18-Nov-21 4:32 PM View: | Stankovich Thomas Chief Financial Officer | Reshape Lifesciences Inc. (OBLN) | 18-Nov-21 | Private Purchase | 20,000 | $2.02 | $40,400.00 | 6% 350.01K to 370.01K | |
| 16-Nov-21 4:18 PM View: | Bandy Barton P. President and CEO Director | Reshape Lifesciences Inc. (OBLN) | 02-Nov-21 | Market Sale | 13,505 | $2.69 | $36,328.40 | (2%) 878.95K to 865.44K | (240%) |
| 16-Nov-21 4:14 PM View: | Stankovich Thomas Chief Financial Officer | Reshape Lifesciences Inc. (OBLN) | 02-Nov-21 | Market Sale | 4,320 | $2.69 | $11,620.80 | (1%) 354.33K to 350.01K | (240%) |
| 12-Oct-21 7:35 PM View: | Bandy Barton P. President and CEO Director | Reshape Lifesciences Inc. (OBLN) | 01-Oct-21 | Market Sale | 12,565 | $2.77 | $34,805.10 | (1%) 891.51K to 878.95K | (230%) |
| 12-Oct-21 7:40 PM View: | Stankovich Thomas Chief Financial Officer | Reshape Lifesciences Inc. (OBLN) | 01-Oct-21 | Market Sale | 3,660 | $2.76 | $10,101.60 | (1%) 357.99K to 354.33K | (232%) |
| 17-Sep-21 6:37 PM View: | Gladney Dan W Director | Reshape Lifesciences Inc. (OBLN) | 10-Sep-21 | Market Sale | 200,000 | $2.99 | $598,000.00 | (41%) 483.92K to 283.92K | |
| 17-Sep-21 7:07 PM View: | Bandy Barton P. President and CEO Director | Reshape Lifesciences Inc. (OBLN) | 10-Sep-21 | Market Sale | 294,494 | $2.89 | $851,088.00 | (25%) 1.19M to 891.51K | |
| 17-Sep-21 6:51 PM View: | Stankovich Thomas Chief Financial Officer | Reshape Lifesciences Inc. (OBLN) | 10-Sep-21 | Market Sale | 48,366 | $2.89 | $139,778.00 | (12%) 406.36K to 357.99K | |
| 31-Aug-21 4:31 PM View: | Stankovich Thomas Chief Financial Officer | Reshape Lifesciences Inc. (OBLN) | 30-Aug-21 | Market Purchase | 15,000 | $3.43 | $51,435.00 | 85% 17.61K to 32.61K | 167% |
| 24-Aug-21 8:59 AM View: | Stankovich Thomas Chief Financial Officer | Reshape Lifesciences Inc. (OBLN) | 20-Aug-21 | Market Purchase | 15,000 | $3.22 | $48,285.00 | 574% 2.61K to 17.61K | 184% |
| 17-Sep-21 6:51 PM View: | Stankovich Thomas Chief Financial Officer | Reshape Lifesciences Inc. (OBLN) | 22-Jul-21 | Grant | 372,744 | -- | -- | 1109% 33.61K to 406.36K | |
| 17-Sep-21 7:07 PM View: | Bandy Barton P. President and CEO Director | Reshape Lifesciences Inc. (OBLN) | 22-Jul-21 | Grant | 1,186,010 | -- | -- | 100% 0 to 1.19M |
